The expression of mammalian target of rapamycin (mTOR), a serine/threonine kinase, which promotes the survival and proliferation of biliary tract cancer cells, is frequently upregulated in advanced biliary tract cancers.120, 121. This evidence concerns the gene MARK2 and biliary tract neoplasm.